Moving agentic AI from demo to R&D acceleration
Collaboration with Microsoft on the Microsoft Discovery agentic platform for scientific R&D reveals that the real impact is acceleration not automation
Harnessing hybrid labs to accelerate R&D innovation
Hybrid labs, or labs-in-the-loop, are the future of R&D innovation. These holistically engineered labs fuse physical experimentation, data, automation and AI to accelerate development into real-world impact.
Rethinking diagnostics in the fight against antimicrobial resistance
Alejandra Sanchez and Ben Wicks explore why primary care needs timely, pragmatic insight, not lab-grade certainty, to enable better antibiotic decisions and stewardship.
Unlocking the potential of IP-free gene editing to gain commercial advantage
CC’s transdisciplinary development team has created a way to democratise gene editing. This IP-free gene editing method avoids the timescales and costs involved with commercially licensing current CRISPR/Cas9 editing techniques.
Engineering biology is driving the new bio-industrial revolution
Engineering biology, the fusion of biology and engineering principles, will be key to solving some of humanity’s most urgent challenges – from climate change and food security to healthcare and more
Quantum computing in 2025: from dream to deployment
Quantum computing has moved from theory and science fiction to become a strategy for business growth, with transformative rewards for those willing to engage with its complexities